Historique
Bulletin de Périodique
European Addiction Research , Vol.31, n°1 - April 2025
Paru le :
01/04/2025
Année
2025
Page(s) :
1-85
Langue(s) :
Anglais
Discipline :
SOM (Sommaire de périodique / Journal contents)
Note de contenu :
CONTENTS:
- Patients with opioid use disorder choosing treatment with extended-release naltrexone: A 6-month naturalistic study. Brenna I.H., Waleur K.M., Benth J.S., Solli K.K., Mordal J., Loberg E.M., et al., p. 1-12.
- Psychometric evaluation of the Dutch version of the Substance Use Recovery Evaluator (SURE-NL). Migchels C., van den Brink W., Zerrouk A., Matthys F.I.A., De Ruysscher C., Debeer D., et al., p. 13-22.
- Exploring recovery priorities in inpatient addiction treatment: A Q-methodological study. Pars E., VanDerNagel J.E.L., Dijkstra B.A.G., Schellekens A.F.A., p. 23-34.
- ESCAPE Study: Cannabidiol use in patients treated for substance use disorders, prevalence of use, and characteristics of users. Duval M., Istvan M., Rousselet M., Laforgue E.J., Grall-Bronnec M., Mauriat C., et al., p. 35-46.
- Effectiveness of machine learning-based adjustments to an eHealth intervention targeting mild alcohol use. Derksen M., van Beek M., Blankers M., Nasri H., de Bruijn T., Lommerse N., et al., p. 47-59.
- Words versus strands: Reliability and stability of concordance rates of self-reported and hair-analyzed substance use of young adults over time. Janousch C., Eggenberger L., Steinhoff A., Johnson-Ferguson L., Bechtiger L., Loher M., et al., p. 60-74.
- Global assessment of training needs in addiction medicine. DeJong C.A.J., Welle-Strand G., Hanafi E., Pinxten L., Bhad R., Arunogiri S., p. 75-86.
- Patients with opioid use disorder choosing treatment with extended-release naltrexone: A 6-month naturalistic study. Brenna I.H., Waleur K.M., Benth J.S., Solli K.K., Mordal J., Loberg E.M., et al., p. 1-12.
- Psychometric evaluation of the Dutch version of the Substance Use Recovery Evaluator (SURE-NL). Migchels C., van den Brink W., Zerrouk A., Matthys F.I.A., De Ruysscher C., Debeer D., et al., p. 13-22.
- Exploring recovery priorities in inpatient addiction treatment: A Q-methodological study. Pars E., VanDerNagel J.E.L., Dijkstra B.A.G., Schellekens A.F.A., p. 23-34.
- ESCAPE Study: Cannabidiol use in patients treated for substance use disorders, prevalence of use, and characteristics of users. Duval M., Istvan M., Rousselet M., Laforgue E.J., Grall-Bronnec M., Mauriat C., et al., p. 35-46.
- Effectiveness of machine learning-based adjustments to an eHealth intervention targeting mild alcohol use. Derksen M., van Beek M., Blankers M., Nasri H., de Bruijn T., Lommerse N., et al., p. 47-59.
- Words versus strands: Reliability and stability of concordance rates of self-reported and hair-analyzed substance use of young adults over time. Janousch C., Eggenberger L., Steinhoff A., Johnson-Ferguson L., Bechtiger L., Loher M., et al., p. 60-74.
- Global assessment of training needs in addiction medicine. DeJong C.A.J., Welle-Strand G., Hanafi E., Pinxten L., Bhad R., Arunogiri S., p. 75-86.
Cote :
Abonnement électronique
Dépouillements
Ajouter le résultat à votre sélection
C. JANOUSCH ;
L. EGGENBERGER ;
A. STEINHOFF ;
L. JOHNSON-FERGUSON ;
L. BECHTIGER ;
M. LOHER ;
D. RIBEAUD ;
M. EISNER ;
M. R. BAUMGARTNER ;
T. M. BINZ ;
L. SHANAHAN ;
B. B. QUEDNOW
|
2025
Dans European Addiction Research (Vol.31, n°1, April 2025) Article : Périodique
Dans European Addiction Research (Vol.31, n°1, April 2025) Article : Périodique
INTRODUCTION: Population-level substance use research primarily relies on self-reports, which often underestimate actual use. Hair analyses offer a more objective estimate; however, longitudinal studies examining concordance are lacking. Previou[...]
M. DUVAL ;
M. ISTVAN ;
M. ROUSSELET ;
E. J. LAFORGUE ;
M. GRALL-BRONNEC ;
C. MAURIAT ;
C. VICTORRI-VIGNEAU
|
2025
Dans European Addiction Research (Vol.31, n°1, April 2025) Article : Périodique
Dans European Addiction Research (Vol.31, n°1, April 2025) Article : Périodique
INTRODUCTION: Cannabidiol (CBD) is one of the two primary phytocannabinoids found in cannabis. Its diverse pharmacological properties suggest potential benefits for a wide range of medical conditions. The primary objective of this study was to e[...]